Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: Efficacy, safety, and cost analysis

Diabetes Care

Volumn 26, Issue 8, 2003, Pages 2238-2243

  Schwartz, Sherwyn ^a   Sievers, Richard ^b   Strange, Poul ^e   Lyness, William H ^c   Hollander, Priscilla ^d  

^a Diabetes and Glandular Disease Clinic   (United States)

^b Wells Institute for Health Awareness   (United States)

^c NOVO NORDISK INC   (United States)

^d BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; ISOPHANE INSULIN; METFORMIN; NOVOLIN R; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE;

ADULT; ALLERGIC REACTION; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG COST; DRUG DOSE REDUCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PYELONEPHRITIS;

ADMINISTRATION, ORAL; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG COSTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; METFORMIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0042024833     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.8.2238     Document Type: Article

References (15)

1. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34): UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:854-865, 1998
2. Tuomilento J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Lianne-Parikka P, Keinanen-Kiukaanniami S, Laakae M, Louheranta A, Rastas M Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
3. Horton ES: Role and management of exercise in diabetes mellitus. Diabetes Care 11:201-211, 1988
4. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
5. Wing RR, Venditti E, Jakicic JM, Polley BA, Lang W: Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 21:350-359, 1998
6. Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC: UKPDS 26: sulphonylurea failure in non-insulin diabetic patients over six years: UK Prospective Diabetes Study (UKPDS) Group. Diabet Med 15:297-303, 1998
7. Turner RC, Cull CA, Frighi V, Holman RR: Glycemic control with diet, sulfonylurea, metformin or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49): UK Prospective Diabetes Study (UKPDS) Group. JAMA 281:2005-2012, 1999
8. Moellma ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM: Insulin treated diabetes patients with fear of self-injecting or fear of self testing: psychological comorbidity and general well-being. J Psychosom Res 51:655-672, 2001
9. Inzucchi SE: Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 287:360-372, 2002
10. Jaber LA, Nowak SN, Slaughter RR: Insulin-metformin combination therapy in obese patients with type 2 diabetes. J Clin Pharmacol 25:89-94, 2002
11. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
12. Winocour PH: Effective diabetes care: a need for realistic targets. BMJ 324:1577-1580, 2002
13. Peacock I, Tattersall RB: The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? BMJ 288:1956-1959, 1984
14. Taylor R: Insulin for the non-insulin dependent. BMJ 296:1015, 1988
15. de Grauw WJC, Van de Lisdonk EH, van Gerwen WHEM, van den Hoogen HJM, van Weel C: Insulin therapy in poorly controlled type 2 diabetic patients: does it affect quality of life? Br J Gen Pract 51:527-532, 2001